Literature DB >> 12753287

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells.

Ken-ichi Tsuchida1, Yanqing Zhu, Senthuran Siva, Stephen R Dunn, Kumar Sharma.   

Abstract

BACKGROUND: The best characterized signaling pathway employed by transforming growth factor-beta (TGF-beta) is the Smad pathway; however, its role in matrix production in mesangial cells is unclear. We focused on Smad4, as Smad4 is essential for the activation of Smad-dependent target genes.
METHODS: To investigate the function of Smad4 in extracellular matrix (ECM) production, we generated several stably transfected mesangial cell lines (MMC) that have a deletion in the linker region (Smad4 Delta M4: Delta 275-322) or have a deletion in MH1 of Smad4 (Smad4N4: Delta 1-136). The ECM genes, alpha1 type I collagen (COL1A1), plasminogen activator inhibitor-1 (PAI-1) and fibronectin (FN) were assessed in wild-type mesangial cells and stably transfected Smad4-DN cell lines in the absence and presence of TGF-beta.
RESULTS: As compared to wild-type MMC that had a 10.8-fold stimulation of TGF-beta-induced p3TP-Lux activity, MMC stably transfected with Smad4 Delta M4 and Smad4N4 had only a 2.0-fold and 1.3-fold stimulation, respectively, indicating that they had dominant-negative effects on TGF-beta signaling. Basal and TGF-beta-induced COL1A1 expression in Smad4 dominant-negative cells were dramatically reduced to very low levels. The early (2 hours) TGF-beta-induced PAI-1 mRNA expression was inhibited; however, the sustained (24 to 48 hours) TGF-beta-induced expression was not affected in Smad4 dominant-negative cells. For FN, TGF-beta-induced expression was maintained in Smad4-dominant negative cells.
CONCLUSION: These results indicate that Smad4 is essential for basal and TGF-beta-induced COL1A1 expression, and contributes to the early, but not sustained TGF-beta-induced PAI-1 expression in mesangial cells. However, TGF-beta-induced FN expression is independent of Smad4. In conclusion, Smad4 has a discriminate effect in mediating specific ECM molecules stimulated by TGF-beta in mesangial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753287     DOI: 10.1046/j.1523-1755.2003.00009.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

3.  Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells.

Authors:  Taishan Hu; Satish P Ramachandrarao; Senthuran Siva; Cathryn Valancius; Yanqing Zhu; Kalyankar Mahadev; Irene Toh; Barry J Goldstein; Marilyn Woolkalis; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

4.  Essential role of endothelial Smad4 in vascular remodeling and integrity.

Authors:  Yu Lan; Bing Liu; Huiyu Yao; Fangfei Li; Tujun Weng; Guan Yang; Wenlong Li; Xuan Cheng; Ning Mao; Xiao Yang
Journal:  Mol Cell Biol       Date:  2007-08-27       Impact factor: 4.272

Review 5.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

Review 6.  Role of Smad signaling in kidney disease.

Authors:  Yanhua Zhang; Songyan Wang; Shengmao Liu; Chunguang Li; Ji Wang
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

7.  Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes.

Authors:  Hang Yuan; Linda Lanting; Zhong-Gao Xu; Shu-Lian Li; Piotr Swiderski; Sumanth Putta; Mahesh Jonnalagadda; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

Review 8.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.

Authors:  Fengyun Xu; Changwei Liu; Dandan Zhou; Lei Zhang
Journal:  J Histochem Cytochem       Date:  2016-01-08       Impact factor: 2.479

9.  Pirfenidone is renoprotective in diabetic kidney disease.

Authors:  Satish P RamachandraRao; Yanqing Zhu; Timothy Ravasi; Tracy A McGowan; Irene Toh; Stephen R Dunn; Shinichi Okada; Michael A Shaw; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 10.121

10.  The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration.

Authors:  Anna Tsapara; Phillip Luthert; John Greenwood; Caroline S Hill; Karl Matter; Maria S Balda
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.